Clinical efficacy and safety of favipiravir in the treatment of COVID-19 patients

被引：17
|
作者：
Chen, Ping-Jen [1 ]
Chao, Chien-Ming [2 ]
Lai, Chih-Cheng [3 ]
机构：
[1] Chi Mei Med Ctr, Dept Surg, Tainan, Taiwan
[2] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan
[3] Kaohsiung Vet Gen Hosp, Tainan Branch, Dept Internal Med, Tainan, Taiwan
来源：
JOURNAL OF INFECTION | 2021年 / 82卷 / 05期
关键词：
D O I：
10.1016/j.jinf.2020.12.005
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：199 / 200
页数：2
相关论文
共 50 条
  • [1] The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
    Soheil Hassanipour
    Morteza Arab-Zozani
    Bahman Amani
    Forough Heidarzad
    Mohammad Fathalipour
    Rudolph Martinez-de-Hoyo
    [J]. Scientific Reports, 11
  • [2] The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
    Hassanipour, Soheil
    Arab-Zozani, Morteza
    Amani, Bahman
    Heidarzad, Forough
    Fathalipour, Mohammad
    Martinez-de-Hoyo, Rudolph
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [3] Addendum: The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
    Soheil Hassanipour
    Morteza Arab-Zozani
    Bahman Amani
    Forough Heidarzad
    Mohammad Fathalipour
    Rudolph Martinez-de-Hoyo
    [J]. Scientific Reports, 12
  • [4] The safety and adverse event profile of favipiravir in the treatment of COVID-19 patients, Turkey
    Tigen, Elif Tukenmez
    Sengel, Buket Erturk
    Ozben, Beste
    Gurun, Hande Perk
    Balcan, Baran
    Bilgili, Beliz
    Gul, Fethi
    Odabasi, Zekaver
    Korten, Volkan
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2023, 17 (11): : 1549 - 1555
  • [5] Comparison of Liver Safety of Favipiravir and Hydroxychloroquine in COVID-19 Treatment
    Izci-Cetinkaya, Feyza
    Karagoz, Hatice
    Yildiz, Orhan
    [J]. KLIMIK JOURNAL, 2020, 33 (03) : 235 - 240
  • [6] A review of the safety of favipiravir - a potential treatment in the COVID-19 pandemic?
    Pilkington, Victoria
    Pepperrell, Toby
    Hill, Andrew
    [J]. JOURNAL OF VIRUS ERADICATION, 2020, 6 (02) : 45 - 51
  • [7] Efficacy and Safety of New and Emerging Drugs for COVID-19: Favipiravir and Dexamethasone
    Sood S.
    Bhatia G.K.
    Seth P.
    Kumar P.
    Kaur J.
    Gupta V.
    Punia S.
    Tuli H.S.
    [J]. Current Pharmacology Reports, 2021, 7 (2) : 49 - 54
  • [8] EFFECTIVENESS AND SAFETY OF FAVIPIRAVIR INFUSION IN PATIENTS HOSPITALIZED WITH COVID-19
    Balykova, L. A.
    Zaslavskaya, K. Ya.
    Pavelkina, V. F.
    Pyataev, N. A.
    Selezneva, N. M.
    Kirichenko, N. V.
    Ivanova, A. Yu.
    Rodoman, G. V.
    Kolontarev, K. B.
    Skrupsky, K. S.
    Simakina, E. N.
    Mubarakshina, O. A.
    Taganov, A. V.
    Pushkar, D. Yu.
    [J]. PHARMACY & PHARMACOLOGY-FARMATSIYA I FARMAKOLOGIYA, 2022, 10 (01): : 113 - 126
  • [9] Efficacy of Favipiravir in the Treatment of Moderate COVID-19 Patients: A Randomized, Open-label, Controlled Clinical Trial
    Tehrani, Shabnam
    Yadegarynia, Davood
    Bagherzade, Afshin
    Gachkar, Latif
    Keyvanfar, Amirreza
    [J]. MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2022, 11
  • [10] A Single-Centered Cohort Study on Favipiravir Safety and Efficacy in Pediatric Patients with COVID-19
    Tabatabaei, Sedigheh Rafiei
    Moradi, Omid
    Karimi, Abdollah
    Armin, Shahnaz
    Fahimzad, Alireza
    Ghanaie, Roxana Mansour
    Jamee, Mahnaz
    Mousavizadeh, Azam
    Amini, Hossein
    Mirrahimi, Bahador
    [J]. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (01):
12345